Cell-based assays were used to characterize biological activities of compound 1 in MLL-r leukemia cell lines Molm-13 and MV4-11 harboring MLL-AF9 and MLL-AF4 fusions, respectively. The gene discussed is MLLT3; the disease is leukemia.